Organization | Prince Sultan Cardiac Center, Riyadh

Prince Sultan Cardiac Center, Riyadh Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial

2008

NCT01260519

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2011

Timeline

NOW

Now

Alternative names

Prince Sultan Cardiac Center, Adult Cardiology Department. | Prince Sultan Cardiac Center (PSCC), Riyadh | Prince Sultan Cardiac Centre (PSCC)

Active Ingredients

Drugs in Phase 3 Trials (5)

acetylsalicylic acid (aspirin) (1 trial)

clopidogrel (plavix) (1 trial)

heparin (liquaemin) (1 trial)

prasugrel (effient) (1 trial)

tirofiban (aggrastat) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Coronary Artery Disease (Phase 3)

Overview

Highest Phase: Phase 3
# of Trials: 2
# of Trial APIs: 5